SEC Filing Summary: Alphabet Inc. Form 13F
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by Alphabet Inc. for the reporting period ending December 31, 2018. The document discloses Alphabet's equity holdings in other public companies as required by the Securities and Exchange Commission. It does not contain Alphabet's own financial performance data (revenue, profit, or cash flow).
Key Financial Metrics
The filing text does not provide Alphabet's internal financial metrics such as revenue, profit, margins, debt, or liquidity. Instead, it lists the value of Alphabet's external equity investments. The table details holdings in 17 distinct issuers, with values reported in thousands of dollars.
| Issuer | Shares/Units | Value ($000s) | Voting Authority |
|---|---|---|---|
| JD.com Inc | 283,674 | 13,553,474 | Sole |
| SVMK Inc | 56,549 | 4,608,705 | None |
| Magenta Therapeutics Inc | 19,033 | 3,339,138 | Sole |
| Snap Inc | 14,428 | 2,618,548 | None |
| Forty Seven Inc | 24,303 | 1,545,966 | Sole |
| DocuSign Inc | 46,945 | 1,171,284 | Sole/None |
| Zscaler Inc | 46,648 | 1,189,688 | None |
| Spero Therapeutics Inc | 6,842 | 1,112,473 | Sole |
| Evelo Biosciences Inc | 13,797 | 1,060,495 | Sole |
| Gritstone Oncology Inc | 14,353 | 929,022 | Sole |
| Arris Intl Inc | 232,439 | 7,603,500 | Sole |
| Arcus Biosciences Inc | 54,386 | 5,049,786 | Sole |
| Cloudera Inc | 4,730 | 427,710 | Sole |
| Dexcom Inc | 3,266 | 110,457 | None |
| Dropbox Inc | 266 | 13,033 | Sole |
| Square Inc | 692 | 12,342 | Sole |
Material Changes and Outlook
The filing text does not provide comparative data against the prior period, nor does it contain management commentary, guidance, or outlook regarding Alphabet's future performance. The document is a static snapshot of holdings as of the reporting date. No risks or contingencies specific to Alphabet's operations are disclosed in this text.
Investor Verification Checklist
- Investment Strategy: Verify if the disclosed holdings (heavy concentration in biotech and tech) align with Alphabet's stated venture capital or strategic investment goals.
- Valuation Impact: Confirm the total value of these holdings against Alphabet's quarterly 10-Q or 10-K filings to assess their impact on total assets.
- Voting Rights: Note that Alphabet holds "Sole" voting authority for most positions but "None" for others (e.g., Snap Inc, Dexcom, SVMK), indicating potential passive investment structures for the latter.
- Missing Data: Acknowledge that this filing does not report Alphabet's core operating revenue or net income; refer to Form 10-K for those metrics.